Olivia Kelly
PhD Student, Pharmacology
Education:
2023 Gannon University, B.S. (Biology)
2023 Gannon University, B.S. (Psychology)
Bio/Research Interests:
After coming to Vanderbilt in 2023 through the Interdisciplinary Graduate Program in Biological and Biomedical Sciences (IGP), I joined the Hamm lab, where I currently study the role of protease-activated receptor 4 (PAR4) in various inflammatory conditions. Specifically, I am interested in PAR4 overexpression in Alzheimer’s disease (AD) and vascular cognitive impairment and dementia (VCID).
Publications:
Kelly O, Sullivan J, Carris N, Geci S, Martinez A, Liashenko V, Colvin J, Misko E, Vanderlaan G, Liu H, Dalvi PS. The impact of diabetes mellitus on the development of psychiatric and neurological disorders. Brain Disorders. 2024 April 17; 14:100135. Available from: https://www.sciencedirect.com/science/article/pii/S2666459324000209 DOI: 10.1016/j.dscb.2024.100135
Hawkey AB, Natarajan S, Kelly O, Gondal A, Wells C, Jones ML, Rezvani AH, Murphy SK, Levin ED. Persisting neurobehavioral consequences of daily or intermittent paternal cannabis administration in F1 and F2 Rats. Neurotoxicology. 2024 May 27;103:27-38. PubMed ID: 38810733.